Online first
Letter to the Editors
Published online: 2024-04-02

open access

Page views 181
Article views/downloads 144
Get Citation

Connect on Social Media

Connect on Social Media

Migraine in the elderly — diagnosis and treatment: a single-centre experience

Izabela Domitrz1

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1545–1602.
  2. Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017; 372: 307–315.
  3. Lipton RB, Steward WF. Migraine in the United States: a review of epidemiology and health care use. Neurology. 1993; 43: S6–10.
  4. Buse DC, Fanning KM, Reed ML, et al. Life With Migraine: Effects on Relationships, Career, and Finances From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache. 2019; 59(8): 1286–1299.
  5. Stovner Lj, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3): 193–210.
  6. Riggins N, Ehrlich A. Episodic Migraine and Older Adults. Curr Pain Headache Rep. 2022; 26(4): 331–335.
  7. Lipton RB, Stewart WF, Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001; 41(7): 646–657.
  8. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008; 7(4): 354–361.
  9. Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet. 2021; 397(10283): 1485–1495.
  10. Dees B, Coleman-Jackson R, Hershey LA. Managing migraine and other headache syndromes in those over 50. Maturitas. 2013; 76(3): 243–246.
  11. Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980; 7(1): 9–17.
  12. Young WB. A knockout punch: C. Miller Fisher's migraine accompaniments. Headache. 2008; 48(5): 726–727.
  13. Ramadan NM, Levine SR, Welch KM. Cerebral blood flow in migraine accompaniments and vertebrobasilar ischemia. Stroke. 1994; 25(6): 1219–1222.
  14. Ferbert A, Brückmann H, Drummen R. Clinical features of proven basilar artery occlusion. Stroke. 1990; 21(8): 1135–1142.
  15. Hershey LA, Bednarczyk EM. Treatment of headache in the elderly. Curr Treat Options Neurol. 2013; 15(1): 56–62.
  16. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33(9): 629–808.
  17. Soni PP, Lee M, Shadbehr N, et al. Recent Advances in the Management of Migraine in Older Patients. Drugs Aging. 2020; 37(7): 463–468.
  18. Gonzalez-Martinez A, Sanz-García A, García-Azorín D, et al. Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study. Pain Med. 2024; 25(3): 194–202.
  19. Muñoz-Vendrell A, Campoy S, Caronna E, et al. Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients. J Headache Pain. 2023; 24(1): 63.
  20. Katsuki M, Kashiwagi K, Kawamura S, et al. Fremanezumab for Migraine Prevention in Japanese Elderly Aged Over 70 Years Old. Cureus. 2023; 15(1): e34052.



Neurologia i Neurochirurgia Polska